An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
复制标题
DOI：
10.1016/j.ygyno.2017.03.022
复制
发表时间：
2017-07-01
影响因子：
4.7
通讯作者：
Chen, Lee-may
中科院分区：
文献类型：
--
作者：
Salani, Ritu;Khanna, Namita;Chen, Lee-may
妇科癌症占女性所有新发癌症病例的12%，占所有女性癌症幸存者的15%。目前和继续在实地取得的进展产生了长期成果和较高的幸存者比率。因此，确定检测复发的最具成本效益的临床监测是至关重要的。不幸的是，在患者达到完全应答后，关于最有效的监测策略的研究一直很少。目前，大多数建议都是基于回顾研究和专家意见。彻底的病史、彻底的检查和对癌症幸存者进行有关症状的教育是检测大多数妇科癌症复发的最有效方法。很少有证据表明常规细胞学或影像检查能提高检测妇科癌症复发的能力，这会影响治愈或抢救治疗的应答率。这篇文章提供了对初次癌症治疗完全有效的妇女的妇科癌症复发监测的最新进展。(C)2017 Elsevier Inc.保留所有权利。
Gynecologic cancers account for similar to 12% of all new cancer cases in women and similar to 15% of all female cancer survivors. Current and continued advances within the field have resulted in long-term outcomes and a high rate of survivors. Therefore determining the most cost-effective clinical surveillance for detection of recurrence is critical. Unfortunately, there has been a paucity of research regarding the most effective strategies for surveillance after patients have achieved a complete response. Currently, most recommendations are based on retrospective studies and expert opinion. Taking a thorough history, performing a thorough examination, and educating cancer survivors about concerning symptoms are the most effective methods for the detection of most gynecologic cancer recurrences. There is very little evidence that routine cytology or imaging improves the ability to detect gynecologic cancer recurrence that will impact cure or response rates to salvage therapy. This article provides an update on surveillance for gynecologic cancer recurrence in women who have had a complete response to primary cancer therapy. (C) 2017 Elsevier Inc. All rights reserved.